The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study

• मुख्य लेखकों: Nuttakant Nontawong (लेखक), Taweegrit Siripongboonsitti (लेखक), Kriangkrai Tawinprai (लेखक), Mana Boonpratoom (लेखक), Nawin Krailassiri (लेखक), Chayaporn Boonkhum (लेखक), Kamonwan Soonklang (लेखक), Yong Poovorawan (लेखक), Nithi Mahanonda (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2022-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Coronavirus disease 2019 (COVID-19) causes life-threatening pneumonia. Convalescent plasma therapy (CPT) is expected to be the effective COVID-19 treatment for passive immunity. The high neutralizing antibodies titer of CPT is needed to prove the benefit in early developed severe...